Caption Management LLC Purchases New Stake in Ardent Health Partners, LLC (NYSE:ARDT)

Caption Management LLC bought a new stake in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The firm bought 33,148 shares of the company's stock, valued at approximately $566,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. US Bancorp DE acquired a new position in Ardent Health Partners during the 4th quarter worth $31,000. R Squared Ltd acquired a new position in shares of Ardent Health Partners during the 4th quarter worth about $37,000. New York State Common Retirement Fund bought a new position in shares of Ardent Health Partners during the 4th quarter valued at about $48,000. Wells Fargo & Company MN raised its stake in shares of Ardent Health Partners by 52.6% during the 4th quarter. Wells Fargo & Company MN now owns 8,704 shares of the company's stock worth $149,000 after purchasing an additional 3,002 shares in the last quarter. Finally, JPMorgan Chase & Co. bought a new stake in shares of Ardent Health Partners during the 3rd quarter worth approximately $154,000.

Ardent Health Partners Stock Up 2.4%

Shares of Ardent Health Partners stock traded up $0.36 during trading on Monday, reaching $14.88. The company had a trading volume of 79,568 shares, compared to its average volume of 396,781. The company has a market cap of $2.12 billion and a price-to-earnings ratio of 9.10. Ardent Health Partners, LLC has a fifty-two week low of $11.31 and a fifty-two week high of $20.72. The firm's fifty day moving average is $13.09 and its 200-day moving average is $14.92. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, beating analysts' consensus estimates of $0.21 by $0.08. The business had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.50 billion. On average, analysts anticipate that Ardent Health Partners, LLC will post 1.23 EPS for the current year.

Analyst Ratings Changes

Several research firms have recently issued reports on ARDT. Royal Bank of Canada reduced their target price on Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating on the stock in a report on Tuesday, March 4th. Guggenheim upped their target price on Ardent Health Partners from $16.00 to $18.00 and gave the company a "buy" rating in a report on Friday. Mizuho lowered their target price on Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Morgan Stanley decreased their target price on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a research report on Tuesday, January 21st. Finally, Stephens restated an "overweight" rating and issued a $22.00 target price on shares of Ardent Health Partners in a research note on Tuesday, April 1st. Two investment analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, Ardent Health Partners presently has a consensus rating of "Buy" and an average price target of $20.75.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.